Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Fast facts: multiple sclerosis.
The MacBlue Binary Transgene (csf1r-gal4VP16/UAS-ECFP) Provides a Novel Marker for Visualisation of Subsets of Monocytes, Macrophages and Dendritic Cells and Responsiveness to CSF1 Administration.
Anodal transcranial direct current stimulation of motor cortex does not ameliorate spasticity in multiple sclerosis.
Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients.
[Local reactions to disease-modifying drugs: pathogenesis and relationship to clinical effectiveness.]
The clinical overlap of multiple sclerosis and headache.
Relating health-related Quality of Life to disability progression in multiple sclerosis, using the 5-level EQ-5D.
Identity-by-Descent Mapping to Detect Rare Variants Conferring Susceptibility to Multiple Sclerosis.
Balkans syndrome: a potential link between multiple sclerosis and hypervaccination.
Neuromuscular adaptations to long-term progressive resistance training translates to improved functional capacity for people with multiple sclerosis and is maintained at follow-up.
Modulating effects of WT1 on interferon-β-vitamin D association in MS.
Aggregation Kinetics for IgG1-Based Monoclonal Antibody Therapeutics.
Behavioral Symptoms in Pediatric Multiple Sclerosis: Relation to Fatigue and Cognitive Impairment.
Multiple sclerosis: Insights into pathophysiology and novel therapeutic avenues.
KIR4.1 Antibodies as Biomarkers in Multiple Sclerosis.
Tissue Transglutaminase in Marmoset Experimental Multiple Sclerosis: Discrepancy between White and Grey Matter.
Oligodendrocytes engineered with migratory proteins as effective graft source for cell transplantation in multiple sclerosis.
Multiple sclerosis: a review of the disease and treatment options.
The ribosomal S6 kinase inhibitor BI-D1870 ameliorated experimental autoimmune encephalomyelitis in mice.
Neuronal activity regulates remyelination via glutamate signalling to oligodendrocyte progenitors.
Erratum to "Methodology of an International Study of People with Multiple Sclerosis Recruited through Web 2.0 Platforms: Demographics, Lifestyle, and Disease Characteristics"
Comparison of the Effect of 8 weeks Aerobic and Yoga Training on Ambulatory Function, Fatigue and Mood Status in MS Patients.
Central Nervous System Demyelination in a Charcot-Marie-Tooth Type 1A Patient.
Comparison of two commercial ELISA systems for evaluating anti-EBNA1 IgG titers.
Cladribine tablets for the treatment of relapsing-remitting multiple sclerosis.
Pages
« first
‹ previous
…
392
393
394
395
396
397
398
399
400
…
next ›
last »